SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-20-000163
Filing Date
2020-11-03
Accepted
2020-11-03 16:07:43
Documents
16
Period of Report
2020-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20201103.htm   iXBRL 8-K 34080
2 EX-99.1 earningsreleaseq1fy21.htm EX-99.1 213931
8 logoa181a.jpg GRAPHIC 6462
  Complete submission text file 0000849146-20-000163.txt   420066

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20201103.xsd EX-101.SCH 2445
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20201103_cal.xml EX-101.CAL 728
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20201103_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20201103_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20201103_pre.xml EX-101.PRE 13208
9 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20201103_htm.xml XML 11187
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 201283559
SIC: 2834 Pharmaceutical Preparations